It was this theme, the importance of equity in digital health, that I spoke about at the Cambridge Wearable Innovation Forum ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...

Zoë Fritz is an Associate Professor in Medical Ethics and Ageing based in THIS Institute and a Consultant Physician in Acute Medicine at Addenbrooke’s Hospital. Her research is focused on identifying ...

Mike grew up in the Seattle area before beginning undergraduate study in 1999 at the University of Washington, where he graduated with BSc’s in biochemistry and economics. As a 19 year-old, Mike began ...

Progress with data technologies, such machine learning and AI, are increasingly inseparable from discussion and application of genomic and other ‘omic technologies. Our analysis considers the key ...

Synthetic data is artificially generated data that reflects the properties and relationships found in real data. While synthetic data can play an important role in AIaMD development, its use in ...

The extension by the UK Government of measures for the lawful processing of confidential patient information (CPI) for COVID-19 purposes is likely to have been welcomed by researchers. Introduced ...

Breast cancer prevention is a focus of many major research programmes. The resulting knowledge is enabling greater accuracy in predicting who will develop breast cancer. Models and tools for ...

Considerable progress has been made in uncovering common single nucleotide variants and developing mechanisms for genomic profiling. Using this knowledge routinely as part of clinical and public ...

This report by PHG Foundation for NHS England, The personalised medicine technology landscape presents an independent evidence synthesis to inform the NHS as it continues to develop its approaches and ...

The impetus for convening this meeting came from recent progress in genomic and related research, particularly as a result of the accelerating generation and accumulation of data, the elaboration of ...

Cost-utility studies provide critical information for the costs and benefits of using any new test, typically building on existing public health and screening programmes, within a defined population.